NCT02667106View on ClinicalTrials.gov

Phase I Pharmacokinetic Study of RX0041-2

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Drug Reaction to Analgesic Nos
Interventions
DRUG

RX0041-2

Pharmacokinetic study

Sponsors
All Listed Sponsors
lead

Pharmaceutical Project Solutions, Inc.

INDUSTRY